Should You Buy Nutrien Stock on a Pullback?

Nutrien (TSX:NTR) stock has seen shares drop back by 24% from 52-week highs and by more than half since all-time highs. But now could be the time to buy.

| More on:
A steel grain silo storage tank with solar panel in a yellow canola field in bloom in Alberta, Canada.

Source: Getty Images

The once-great Nutrien (TSX:NTR) stock is down. But investors should think twice before counting it out. Despite reaching all-time highs of $148, the stock has now slumped by more than half to $70 per share as of writing. What’s more, the company fell by 24% since 52-week highs as well. Yet dig in, and investors may see this as more of an opportunity rather than a worry. So, let’s see why.

What happened?

First off, let’s look at what’s caused the drop in share price in the first place. Nutrien stock experienced a decline in operating margins over the last three quarters. Specifically, margins have decreased from 35% in the second quarter (Q2) of 2022 to 24% in Q4 2022. This contraction is primarily due to increased production costs and fluctuating fertilizer prices, which have squeezed profitability.

Furthermore, the prices of key fertilizers, including potash, nitrogen, and phosphate, have seen a moderation recently. This decline in prices is partly due to changes in global supply and demand dynamics, impacting Nutrien stock’s revenue and overall stock performance.

Fears of an economic recession have dampened the short- to medium-term demand outlook for fertilizers. This uncertainty has led to investor caution, contributing to the drop in Nutrien’s stock price. Although long-term demand prospects remain positive, the current economic climate has introduced volatility and risk.

Digging deeper

A lot of the issues then with Nutrien stock are more about broad market problems, not the stock itself. So, could the stock actually be a buy? To figure that out, we need to look at the company’s fundamental metrics.

First off, Nutrien stock offers a trailing 11.63 price-to-earnings (P/E) ratio and a forward 10.52 P/E ratio. These relatively low P/E ratios suggest that Nutrien might be undervalued compared to its historical performance and the broader market. A lower P/E can indicate a good buying opportunity if the company’s earnings are stable or expected to grow.

The company also provides a trailing price-to-sales (P/S) ratio of 0.83 and a forward of 0.91. A P/S ratio below one generally indicates that the stock is potentially undervalued relative to its revenue. This also makes it an attractive option for value investors.

Its current price-to-book (P/B) ratio of one suggests that the stock is trading at its book value, which might indicate a balanced valuation. As well, it holds a 4.26% dividend yield. A relatively high dividend yield can attract income-focused investors. Nutrien’s commitment to maintaining a strong dividend indicates financial health and a shareholder-friendly approach.

Nutrien stock also holds total debt of $13.64 billion, with a debt-to-equity (D/E) ratio of 0.55. While the company has significant debt, the D/E ratio indicates a moderate level of leverage, which can be manageable if the company continues to generate strong cash flows.

Finally, it holds an operating margin of 8.53%, a profit margin of 7.33%, and a free cash flow of $5.75. These metrics indicate that Nutrien is relatively efficient in generating profit from its operations and equity, which can be a positive sign for investors looking for stable returns. Strong free cash flow supports dividend payments and potential share buybacks, which can enhance shareholder value.

Is it a buy?

Altogether, Nutrien stock exhibits several positive attributes, such as a low P/E ratio, reasonable P/B ratio, and a solid dividend yield, making it potentially attractive for value and income investors. What’s more, analysts believe there is more to come. So, despite fears over potential macro issues in the future, on a micro level, Nutrien stock looks like one excellent buy during this pullback.

Fool contributor Amy Legate-Wolfe has no position in any of the stocks mentioned. The Motley Fool recommends Nutrien. The Motley Fool has a disclosure policy.

More on Dividend Stocks

Piggy bank and Canadian coins
Dividend Stocks

Canadians: Here’s How Much You Need in Your TFSA to Retire

If you hold Fortis Inc (TSX:FTS) stock in a TFSA, you might earn enough dividends to cover part of your…

Read more »

Blocks conceptualizing Canada's Tax Free Savings Account
Dividend Stocks

1 Ideal TFSA Stock Paying 7% Income Every Month

A TFSA can feel like payday with a monthly payer like SmartCentres, but the real “winner” test is cash flow…

Read more »

up arrow on wooden blocks
Dividend Stocks

3 Blue-Chip Dividend Stocks for 2026

These blue-chip dividend stocks have consistently grown their dividends, and will likely maintain the dividend growth streak.

Read more »

Nurse talks with a teenager about medication
Dividend Stocks

A Perfect January TFSA Stock With a 6.8% Monthly Payout

A high-yield monthly payer can make a January TFSA reset feel automatic, but only if the cash flow truly supports…

Read more »

alcohol
Dividend Stocks

2 Stocks to Boost Your Income Investing Payouts in 2026

These two Canadian stocks with consistent dividend growth are ideal for income-seeking investors.

Read more »

The TFSA is a powerful savings vehicle for Canadians who are saving for retirement.
Dividend Stocks

TFSA: 4 Canadian Stocks to Buy and Hold Forever

High-yield stocks like Telus are examples of great additions to your tax-free savings account, or TFSA.

Read more »

monthly calendar with clock
Retirement

Retirement Planning: How to Generate $3,000 in Monthly Income

Are you planning for retirement but don't have a cushy pension? Here's how you could earn an extra $3,000 per…

Read more »

A worker overlooks an oil refinery plant.
Dividend Stocks

TFSA Passive Income: 2 TSX Dividend Stocks to Buy on Dips

These stocks have delivered annual dividend growth for decades.

Read more »